Imagine you've just been told you have cancer and all of the emotions and questions that would race through your mind. Next imagine you get news soon after that you're eligible for a clinical trial for treatment that could potentially lengthen or save your life.
Allegheny Health Network ...
New research is showing promise that a vaccine may be able to fight one type of the most common cancers in women.
Phase one clinical trials examined immune response to a new breast cancer vaccine by measuring antibodies in white blood cells. Researchers hope the vaccine could eventually ...
BOULDER, Colo.--(BUSINESS WIRE)--Nov 9, 2023--Edgewise Therapeutics, Inc. (Nasdaq: EWTX), a leading muscle disease biopharmaceutical company, today reported financial results for the third quarter of 2023 and recent business highlights.“I’m thrilled with the progress we’ve made in 2023 ...
SEOUL, Korea--(BUSINESS WIRE)--Nov 9, 2023--GenScript ProBio, a global multimodality CDMO and NuclixBio, a company developing treatments based on circular RNA, announced on 9th Nov that they have entered into a strategic business agreement to develop the first circular RNA-based anticancer drug ...